Cite
HARVARD Citation
O'Brien, K. et al. (n.d.). Efficacy of motavizumab for the prevention of respiratory syncytial virus disease in healthy Native American infants: a phase 3 randomised double-blind placebo-controlled trial. Lancet infectious diseases. 15 (12), pp. 1398-1408. [Online].